Outlook Therapeutics shares owned by Neuberger Berman Group
Quarter-by-quarter ownership of Outlook Therapeutics shares owned by Neuberger Berman Group
from 13F filings
Historical chart of Neuberger Berman Group investment in Outlook Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Outlook Therapeutics held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Outlook Therapeutics by Neuberger Berman Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $13k | 33k | 0.39 |
2023-09-30 | $6.2k | 28k | 0.22 |